世界の日光角化症治療市場規模・現状・予測2021-2027

【英語タイトル】Global Actinic Keratosis Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0037)・商品コード:QY21APR0037
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:91
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、日光角化症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(破壊的治療、光線力学療法、外用薬、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・日光角化症治療の市場動向
・企業の競争状況、市場シェア
・日光角化症治療の種類別市場規模(破壊的治療、光線力学療法、外用薬、その他)
・日光角化症治療の用途別市場規模(病院、クリニック、その他)
・日光角化症治療の北米市場規模2016-2027(アメリカ、カナダ)
・日光角化症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・日光角化症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・日光角化症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・日光角化症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(DUSA Pharmaceuticals、Novartis、Perrigo、LEO Pharma、Bausch Health、Taro Pharmaceutical、Galderma (Nestle)、Biofrontera、Almirall、Tolmar Pharmaceutical)
・結論
【レポートの概要】

Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It’s most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
The classification of Actinic Keratosis Treatment includes Destructive Treatment, Photodynamic Therapy, Topical Medications and Other, and the Most of Actinic Keratosis Treatment is Destructive Treatment, and proportion of Destructive Treatment in 2017 is about 81.4%. Cryotherapy was the most ordinarily looked for treatment by clinicians. Notwithstanding, better clinical consequences of photodynamic treatment and developing inclination for medications in view of medication gadget mix have asked both parental figures and patients to choose novel treatment techniques that offer both propelled adequacy, stylish advantages and decreased danger of future malignancies.

Market Analysis and Insights: Global Actinic Keratosis Treatment Market
The global Actinic Keratosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Actinic Keratosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Actinic Keratosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Actinic Keratosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Actinic Keratosis Treatment market.

Global Actinic Keratosis Treatment Scope and Market Size
Actinic Keratosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Actinic Keratosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Destructive Treatment
Photodynamic Therapy
Topical Medications
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Actinic Keratosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Destructive Treatment
1.2.3 Photodynamic Therapy
1.2.4 Topical Medications
1.2.5 Other
1.3 Market by Application
1.3.1 Global Actinic Keratosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Actinic Keratosis Treatment Market Perspective (2016-2027)
2.2 Actinic Keratosis Treatment Growth Trends by Regions
2.2.1 Actinic Keratosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Actinic Keratosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Actinic Keratosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Actinic Keratosis Treatment Industry Dynamic
2.3.1 Actinic Keratosis Treatment Market Trends
2.3.2 Actinic Keratosis Treatment Market Drivers
2.3.3 Actinic Keratosis Treatment Market Challenges
2.3.4 Actinic Keratosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Actinic Keratosis Treatment Players by Revenue
3.1.1 Global Top Actinic Keratosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Actinic Keratosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Actinic Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Actinic Keratosis Treatment Revenue
3.4 Global Actinic Keratosis Treatment Market Concentration Ratio
3.4.1 Global Actinic Keratosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Actinic Keratosis Treatment Revenue in 2020
3.5 Actinic Keratosis Treatment Key Players Head office and Area Served
3.6 Key Players Actinic Keratosis Treatment Product Solution and Service
3.7 Date of Enter into Actinic Keratosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Actinic Keratosis Treatment Breakdown Data by Type
4.1 Global Actinic Keratosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Actinic Keratosis Treatment Forecasted Market Size by Type (2022-2027)

5 Actinic Keratosis Treatment Breakdown Data by Application
5.1 Global Actinic Keratosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Actinic Keratosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Actinic Keratosis Treatment Market Size (2016-2027)
6.2 North America Actinic Keratosis Treatment Market Size by Type
6.2.1 North America Actinic Keratosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Actinic Keratosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Actinic Keratosis Treatment Market Size by Type (2016-2027)
6.3 North America Actinic Keratosis Treatment Market Size by Application
6.3.1 North America Actinic Keratosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Actinic Keratosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Actinic Keratosis Treatment Market Size by Application (2016-2027)
6.4 North America Actinic Keratosis Treatment Market Size by Country
6.4.1 North America Actinic Keratosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Actinic Keratosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Actinic Keratosis Treatment Market Size (2016-2027)
7.2 Europe Actinic Keratosis Treatment Market Size by Type
7.2.1 Europe Actinic Keratosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Actinic Keratosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Actinic Keratosis Treatment Market Size by Type (2016-2027)
7.3 Europe Actinic Keratosis Treatment Market Size by Application
7.3.1 Europe Actinic Keratosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Actinic Keratosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Actinic Keratosis Treatment Market Size by Application (2016-2027)
7.4 Europe Actinic Keratosis Treatment Market Size by Country
7.4.1 Europe Actinic Keratosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Actinic Keratosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Actinic Keratosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Type
8.2.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Application
8.3.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Actinic Keratosis Treatment Market Size by Region
8.4.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Actinic Keratosis Treatment Market Size (2016-2027)
9.2 Latin America Actinic Keratosis Treatment Market Size by Type
9.2.1 Latin America Actinic Keratosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Actinic Keratosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Actinic Keratosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Actinic Keratosis Treatment Market Size by Application
9.3.1 Latin America Actinic Keratosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Actinic Keratosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Actinic Keratosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Actinic Keratosis Treatment Market Size by Country
9.4.1 Latin America Actinic Keratosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Actinic Keratosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Actinic Keratosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Type
10.2.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Application
10.3.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Actinic Keratosis Treatment Market Size by Country
10.4.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 DUSA Pharmaceuticals
11.1.1 DUSA Pharmaceuticals Company Details
11.1.2 DUSA Pharmaceuticals Business Overview
11.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Introduction
11.1.4 DUSA Pharmaceuticals Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.1.5 DUSA Pharmaceuticals Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Actinic Keratosis Treatment Introduction
11.2.4 Novartis Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Perrigo
11.3.1 Perrigo Company Details
11.3.2 Perrigo Business Overview
11.3.3 Perrigo Actinic Keratosis Treatment Introduction
11.3.4 Perrigo Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.3.5 Perrigo Recent Development
11.4 LEO Pharma
11.4.1 LEO Pharma Company Details
11.4.2 LEO Pharma Business Overview
11.4.3 LEO Pharma Actinic Keratosis Treatment Introduction
11.4.4 LEO Pharma Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.4.5 LEO Pharma Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Actinic Keratosis Treatment Introduction
11.5.4 Bausch Health Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Taro Pharmaceutical
11.6.1 Taro Pharmaceutical Company Details
11.6.2 Taro Pharmaceutical Business Overview
11.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Introduction
11.6.4 Taro Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.6.5 Taro Pharmaceutical Recent Development
11.7 Galderma (Nestle)
11.7.1 Galderma (Nestle) Company Details
11.7.2 Galderma (Nestle) Business Overview
11.7.3 Galderma (Nestle) Actinic Keratosis Treatment Introduction
11.7.4 Galderma (Nestle) Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.7.5 Galderma (Nestle) Recent Development
11.8 Biofrontera
11.8.1 Biofrontera Company Details
11.8.2 Biofrontera Business Overview
11.8.3 Biofrontera Actinic Keratosis Treatment Introduction
11.8.4 Biofrontera Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.8.5 Biofrontera Recent Development
11.9 Almirall
11.9.1 Almirall Company Details
11.9.2 Almirall Business Overview
11.9.3 Almirall Actinic Keratosis Treatment Introduction
11.9.4 Almirall Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.9.5 Almirall Recent Development
11.10 Tolmar Pharmaceutical
11.10.1 Tolmar Pharmaceutical Company Details
11.10.2 Tolmar Pharmaceutical Business Overview
11.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Introduction
11.10.4 Tolmar Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.10.5 Tolmar Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Actinic Keratosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Destructive Treatment
Table 3. Key Players of Photodynamic Therapy
Table 4. Key Players of Topical Medications
Table 5. Key Players of Other
Table 6. Global Actinic Keratosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Actinic Keratosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Actinic Keratosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Actinic Keratosis Treatment Market Share by Regions (2016-2021)
Table 10. Global Actinic Keratosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Actinic Keratosis Treatment Market Share by Regions (2022-2027)
Table 12. Actinic Keratosis Treatment Market Trends
Table 13. Actinic Keratosis Treatment Market Drivers
Table 14. Actinic Keratosis Treatment Market Challenges
Table 15. Actinic Keratosis Treatment Market Restraints
Table 16. Global Actinic Keratosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Actinic Keratosis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Actinic Keratosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic Keratosis Treatment as of 2020)
Table 19. Ranking of Global Top Actinic Keratosis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Actinic Keratosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Actinic Keratosis Treatment Product Solution and Service
Table 23. Date of Enter into Actinic Keratosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Actinic Keratosis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Actinic Keratosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Actinic Keratosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Actinic Keratosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Actinic Keratosis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Actinic Keratosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Actinic Keratosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Actinic Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Actinic Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Actinic Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Actinic Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Actinic Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Actinic Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Actinic Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Actinic Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Actinic Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Actinic Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Actinic Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Actinic Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Actinic Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Actinic Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Actinic Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. DUSA Pharmaceuticals Company Details
Table 64. DUSA Pharmaceuticals Business Overview
Table 65. DUSA Pharmaceuticals Actinic Keratosis Treatment Product
Table 66. DUSA Pharmaceuticals Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 67. DUSA Pharmaceuticals Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Actinic Keratosis Treatment Product
Table 71. Novartis Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Perrigo Company Details
Table 74. Perrigo Business Overview
Table 75. Perrigo Actinic Keratosis Treatment Product
Table 76. Perrigo Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 77. Perrigo Recent Development
Table 78. LEO Pharma Company Details
Table 79. LEO Pharma Business Overview
Table 80. LEO Pharma Actinic Keratosis Treatment Product
Table 81. LEO Pharma Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 82. LEO Pharma Recent Development
Table 83. Bausch Health Company Details
Table 84. Bausch Health Business Overview
Table 85. Bausch Health Actinic Keratosis Treatment Product
Table 86. Bausch Health Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 87. Bausch Health Recent Development
Table 88. Taro Pharmaceutical Company Details
Table 89. Taro Pharmaceutical Business Overview
Table 90. Taro Pharmaceutical Actinic Keratosis Treatment Product
Table 91. Taro Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 92. Taro Pharmaceutical Recent Development
Table 93. Galderma (Nestle) Company Details
Table 94. Galderma (Nestle) Business Overview
Table 95. Galderma (Nestle) Actinic Keratosis Treatment Product
Table 96. Galderma (Nestle) Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 97. Galderma (Nestle) Recent Development
Table 98. Biofrontera Company Details
Table 99. Biofrontera Business Overview
Table 100. Biofrontera Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 101. Biofrontera Recent Development
Table 102. Almirall Company Details
Table 103. Almirall Business Overview
Table 104. Almirall Actinic Keratosis Treatment Product
Table 105. Almirall Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 106. Almirall Recent Development
Table 107. Tolmar Pharmaceutical Company Details
Table 108. Tolmar Pharmaceutical Business Overview
Table 109. Tolmar Pharmaceutical Actinic Keratosis Treatment Product
Table 110. Tolmar Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 111. Tolmar Pharmaceutical Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Actinic Keratosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Destructive Treatment Features
Figure 3. Photodynamic Therapy Features
Figure 4. Topical Medications Features
Figure 5. Other Features
Figure 6. Global Actinic Keratosis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Actinic Keratosis Treatment Report Years Considered
Figure 11. Global Actinic Keratosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Actinic Keratosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Actinic Keratosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Actinic Keratosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Actinic Keratosis Treatment Market Share by Players in 2020
Figure 16. Global Top Actinic Keratosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic Keratosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Actinic Keratosis Treatment Revenue in 2020
Figure 18. Global Actinic Keratosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Actinic Keratosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Actinic Keratosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Actinic Keratosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Actinic Keratosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Actinic Keratosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Actinic Keratosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Actinic Keratosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Actinic Keratosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Actinic Keratosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Actinic Keratosis Treatment Market Share by Region (2016-2027)
Figure 40. China Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Actinic Keratosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Actinic Keratosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Actinic Keratosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Actinic Keratosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Actinic Keratosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Actinic Keratosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Actinic Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. DUSA Pharmaceuticals Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 61. Perrigo Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 62. LEO Pharma Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 64. Taro Pharmaceutical Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 65. Galderma (Nestle) Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 66. Biofrontera Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 67. Almirall Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 68. Tolmar Pharmaceutical Revenue Growth Rate in Actinic Keratosis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

DUSA Pharmaceuticals、Novartis、Perrigo、LEO Pharma、Bausch Health、Taro Pharmaceutical、Galderma (Nestle)、Biofrontera、Almirall、Tolmar Pharmaceutical

★調査レポート[世界の日光角化症治療市場規模・現状・予測2021-2027] (コード:QY21APR0037)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の日光角化症治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆